微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.19% | 30.36% | 41.29% | 46/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 1.55% | -53.59% | -32.61% | 91/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 2.3% | -22.82% | -11.88% | 90/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.61% | 34.54% | 55.36% | 68/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.68% | 5% | -49.7% | 64/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.34% | -43.49% | 12.08% | 73/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.98% | -53% | 53.61% | 86/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.94% | -63.47% | 21.25% | 84/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.6% | -73.29% | -72.93% | 71/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.91% | -67.2% | -6.78% | 54/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.34% | 2% | 19.4% | 51/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.31% | -49.76% | -11.35% | 40/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 5.99% | 2% | -66.76% | 5/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 18.02% | -11.93% | 70.48% | 10/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 10.57% | -9.89% | -48.34% | 10/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2021-12-31 | 20.46% | 0.05% | 74.42% | 10/157 | 0.84% | 小方制药 | 34.81% | 行业排名> |
| 2021-06-30 | 11.73% | 87.38% | -42.64% | 8/157 | 2.99% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | 20.45% | 117.55% | 117.55% | 21/157 | 3.8% | ST人福 | 6.82% | 行业排名> |
| 2019-12-31 | 9.4% | -1.16% | 50.16% | 60/157 | 2.57% | 小方制药 | 71.99% | 行业排名> |
| 2019-06-30 | 6.26% | 734.67% | -34.17% | 36/157 | 5.02% | 汇宇制药 | 39.25% | 行业排名> |
| 2018-12-31 | 9.51% | 2% | 1168% | 53/157 | 7.16% | 汇宇制药 | 28.14% | 行业排名> |
| 2018-06-30 | 0.75% | 2% | 2% | 94/157 | 4.63% | 哈三联 | 27.17% | 行业排名> |